Related Experiment Video

Updated: Jul 13, 2026

LPS and ATP-induced Death of PMA-differentiated THP-1 Macrophages and its Validation
06:12

LPS and ATP-induced Death of PMA-differentiated THP-1 Macrophages and its Validation

Published on: May 3, 2024

Activation of targeted necrosis by a p53 peptide: a novel death pathway that circumvents apoptotic resistance

Richard D Dinnen1, Lisa Drew1, Daniel P Petrylak1

  • 1Experimental Therapeutics Program, Division of Medical Oncology, Columbia University, College of Physicians and Surgeons, New York, New York 10032.

The Journal of Biological Chemistry
|July 20, 2007
PubMed

Insights

A novel peptide, p53p-Ant, induces targeted necrosis in mutant p53 prostate cancer cells, bypassing drug resistance. This targeted necrosis mechanism involves ATP loss and reactive oxygen species, offering a selective cancer cell-killing strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Death Pathways

Background:

  • Cancer cells develop drug resistance by evading apoptosis.
  • Alternative cell death pathways like necrosis are non-specific and cause inflammation.
  • Targeted cell death strategies are needed to overcome apoptosis resistance.

Purpose of the Study:

  • To investigate p53p-Ant peptide's potential to induce targeted necrosis in prostate cancer.
  • To determine if p53p-Ant can circumvent chemotherapy resistance.
  • To elucidate the mechanism of p53p-Ant-induced targeted necrosis.

Main Methods:

  • Treatment of human prostate cancer lines with p53p-Ant peptide.
  • Assessment of cytotoxicity in parental and drug-resistant cell lines.
  • Analysis of ATP levels and reactive oxygen species generation.
  • Inhibition studies using O(2)(.) scavengers.

Main Results:

  • p53p-Ant induced targeted necrosis specifically in mutant p53 prostate cancer cells, not normal cells.
  • Drug-resistant prostate cancer lines showed sensitivity to p53p-Ant.
  • The mechanism involved massive ATP loss and reactive oxygen species generation.
  • Necrosis induction was inhibited by O(2)(.) scavengers.

Conclusions:

  • p53p-Ant peptide induces targeted necrosis dependent on mutant p53 levels.
  • This pathway circumvents apoptosis resistance and chemotherapy resistance.
  • Targeted necrosis offers a specific alternative to non-specific cell death pathways for cancer treatment.

More Related Videos

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death09:18

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death

Published on: December 27, 2016

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...